Gladstone NOW: The Campaign Join Us on the Journey✕
Isha Jain, PhD, and her team developed a drug that mimics the effects of breathing low oxygen, which could be life-saving for people with mitochondrial diseases who rarely survive past childhood. In mice with Leigh Syndrome—the most common childhood mitochondrial disease—the drug extended lifespan three-fold and reversed symptoms, even when given during late stages of disease. The new drug shows the promise of gas-based therapies for mitochondrial diseases and other common brain and cardiovascular conditions for which low oxygen has been shown to be beneficial.
In this video, Jain and research associate Skyler Blume explain the science behind their discovery and the impact it could have for mitochondrial diseases. Read more about this discovery.
Featured Experts
Gladstone NOW: The Campaign
Join Us On The Journey
Engineered Human Neurons Rebuild Damaged Spinal Cord Circuits
Article
August 5, 2026
Engineered Human Neurons Rebuild Damaged Spinal Cord Circuits
Gladstone scientists show that stem cell-derived spinal neurons can integrate into damaged neural networks in rats and improve breathing-related motor function after a traumatic spinal cord injury.
Srivastava Lab Cardiovascular Disease Stem Cells/iPSCs News Release Research (Publication)Heart Disease Genetic Risk: New Study Reveals Why Populations Differ
Article
July 23, 2026
Heart Disease Genetic Risk: New Study Reveals Why Populations Differ
For decades, a DNA-based test for cardiovascular disease seemed to work for Europeans and others but not Africans. Gladstone scientists just discovered why, with implications for many other diseases.
Human Genetics Data Science and Biotechnology Tcheandjieu Lab News Release Research (Publication)Controlling Oxygen to Fight Disease
Article
July 8, 2026
Controlling Oxygen to Fight Disease
New research shows low oxygen can help alleviate disease caused by defects in a mitochondrial quality control machinery.
News Release Research (Publication) Jain Lab Metabolism